Second NJ Trial Underway In Novartis Bone Drug Litigation
Novartis Pharmaceuticals Corp. failed to adequately warn cancer doctors that its bone drug Zometa could cause osteonecrosis in patients' jaws, despite ample links between the medication and bone death, attorneys for...To view the full article, register now.
Already a subscriber? Click here to view full article